EYE 1.39% 18.3¢ nova eye medical limited

EYE Summary (August 2024): Incredibly Undervalued, page-14

  1. bar
    723 Posts.
    lightbulb Created with Sketch. 116
    007 can you compare EYE to those competitors on the financial basis. My only concern is that asx people do not comprehend medtech value . Another of my stocks AVR is going Nasdaq to get funding with their best in class tech. If EYE was in the US it would be a dollar stock at least. Aussies love mining and dividends.
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.